
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Probiotec Limited is a drug manufacturers—specialty & generic business based in Australia. Probiotec shares (PBP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Probiotec has a trailing 12-month revenue of around $107.2 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $1.55 - $2.48 |
---|---|
50-day moving average | $1.7922 |
200-day moving average | $1.9057 |
Target price | N/A |
PE ratio | 18.6006 |
Dividend yield | $0.04 (2.52%) |
Earnings per share (TTM) | $0.05 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$1.795 on 2020-10-22
1 week (2021-01-15) | -27.62% |
---|---|
1 month (2020-12-23) | -21.62% |
3 months (2020-10-23) | 3.16% |
6 months (2020-07-23) | -10.25% |
1 year (2020-01-23) | -19.87% |
---|---|
2 years (2019-01-23) | 19.67% |
3 years (2018-01-23) | 106.32% |
5 years (2016-01-22) | 322.35% |
Valuing Probiotec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Probiotec 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Probiotec 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Probiotec shares trade at around 19x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Probiotec 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14 million (ÂŁ0.0 million).
The EBITDA is a measure of a Probiotec 's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $107.2 million |
---|---|
Operating margin TTM | 10.1% |
Gross profit TTM | $31.8 million |
Return on assets TTM | 5.63% |
Return on equity TTM | 11.68% |
Profit margin | 3.27% |
Book value | 0.809 |
Market capitalisation | $134.6 million |
TTM: trailing 12 months
Dividend payout ratio: 44.44% of net profits
Recently Probiotec has paid out, on average, around 44.44% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Probiotec shareholders could enjoy a 2.52% return on their shares, in the form of dividend payments. In Probiotec 's case, that would currently equate to about A$0.04 per share.
While Probiotec 's payout ratio might seem fairly standard, it's worth remembering that Probiotec may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 22 October 2020 (the "ex-dividend date").
Over the last 12 months, Probiotec 's shares have ranged in value from as little as $1.55 up to $2.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Probiotec 's is 0.2863. This would suggest that Probiotec 's shares are less volatile than average (for this exchange).
Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.
From the best overall face moisturiser for dry skin to the best body moisturiser, hand moisturiser and tinted moisturiser for dry skin, these are the best 7 moisturisers for dry skin you can buy in Australia right now.
From the best RC plane for beginners to the top model for aerial photography, these are the six best RC planes in Australia right now.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.